Description of Research Expertise:
Functional Tumor MR Imaging: DCE-MRI, DWI, MRSI
Morphologic Tumor Response Evaluation
Selected Publications:
Hylton Nola M, Gatsonis Constantine A, Rosen Mark A, Lehman Constance D, Newitt David C, Partridge Savannah C, Bernreuter Wanda K, Pisano Etta D, Morris Elizabeth A, Weatherall Paul T, Polin Sandra M, Newstead Gillian M, Marques Helga S, Esserman Laura J, Schnall Mitchell D: Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL. Radiology 279 (1): 44-55,2016.
Narayan Vivek, Hwang Wei-Ting, Lal Priti, Rosen Mark A, Gallagher Maryann, O'Dwyer Peter J, Vaughn David J: Cyclin-Dependent Kinase 4/6 Inhibition for the Treatment of Unresectable Mature Teratoma: Long-Term Follow-Up of a Phase II Study. Clinical genitourinary cancer s1558-7673 (16): 30064-7,2016.
FitzGerald Thomas J, Bishop-Jodoin Maryann, Followill David S, Galvin James, Knopp Michael V, Michalski Jeff M, Rosen Mark A, Bradley Jeffrey D, Shankar Lalitha K, Laurie Fran, Cicchetti M Giulia, Moni Janaki, Coleman C Norman, Deye James A, Capala Jacek, Vikram Bhadrasain: Imaging and Data Acquisition in Clinical Trials for Radiation Therapy. International journal of radiation oncology, biology, physics 94 (2): 404-11,2016.
Flaherty Keith T, Hamilton Betty K, Rosen Mark A, Amaravadi Ravi K, Schuchter Lynn M, Gallagher Maryann, Chen Helen, Sehgal Chandra, O'Dwyer Peter J: Phase I/II Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers. The Oncologist 20 (8): 952-9,2015.
Chung So Hyun, Feldman Michael D, Martinez Daniel, Kim Helen, Putt Mary E, Busch David R, Tchou Julia, Czerniecki Brian J, Schnall Mitchell D, Rosen Mark A, DeMichele Angela, Yodh Arjun G, Choe Regine: Macroscopic optical physiological parameters correlate with microscopic proliferation and vessel area breast cancer signatures. Breast Cancer Research : BCR 17 : 72,2015.
Vaughn David J, Hwang Wei-Ting, Lal Priti, Rosen Mark A, Gallagher Maryann, O'Dwyer Peter J: Phase 2 trial of the cyclin-dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors. Cancer 121 (9): 1463-8,2015.
Agner Shannon C, Rosen Mark A, Englander Sarah, Tomaszewski John E, Feldman Michael D, Zhang Paul, Mies Carolyn, Schnall Mitchell D, Madabhushi Anant: Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study. Radiology 272 (1): 91-9,2014.
Shlansky-Goldberg Richard D, Rosen Mark A, Mondschein Jeffrey I, Stavropoulos S William, Trerotola Scott O, Diaz-Cartelle Juan: Comparison of polyvinyl alcohol microspheres and tris-acryl gelatin microspheres for uterine fibroid embolization: results of a single-center randomized study. Journal of vascular and interventional radiology : JVIR 25 (6): 823-32,2014.
Choe Regine, Putt Mary E, Carlile Peter M, Durduran Turgut, Giammarco Joseph M, Busch David R, Jung Ki Won, Czerniecki Brian J, Tchou Julia, Feldman Michael D, Mies Carolyn, Rosen Mark A, Schnall Mitchell D, DeMichele Angela, Yodh Arjun G: Optically measured microvascular blood flow contrast of malignant breast tumors. PLoS One 9 (6): e99683,2014.
Ciunci CA, Perini RF, Avadhani AN, Kang HC, Sun W, Redlinger M, Harlacker K, Flaherty KT, Giantonio BJ, Rosen MA, Divgi CR, Song HK, Englander S, Troxel A, Schnall M, O'Dwyer PJ: Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer. Cancer 120 (1): 77-85,2014.